| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| ABT - Abbott Laboratories | HOLD | 0 @ USD 127 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 127. The average price that ABT shares were previous bought at was USD 128.636. The current market price is -1.3% lower than average price they were purchased at. The value of the holding in ABT has increased by USD 268,638 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18.25 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18.25. The average price that BAX shares were previous bought at was USD 27.4613. The current market price is -33.5% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 35,662 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 189.02 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 189.02. The average price that BDX shares were previous bought at was USD 201.977. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in BDX has increased by USD 294,115 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 102.5 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 102.5. The average price that BSX shares were previous bought at was USD 98.19. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 327,616 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 102.5 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 102.5. The average price that BSX shares were previous bought at was USD 98.19. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 327,616 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 58.13 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 58.13. The average price that DXCM shares were previous bought at was USD 75.1618. The current market price is -22.7% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 179,374 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 85.16 | USD 0 | The current share valuation price of EW based on adjusted close was USD 85.16. The average price that EW shares were previous bought at was USD 73.2429. The current market price is 16.3% higher than average price they were purchased at. The value of the holding in EW has increased by USD 88,282 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 73.41 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 73.41. The average price that GEHC shares were previous bought at was USD 74.9346. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in GEHC has fallen by USD 4,444 compared to the previous valuation of GE HealthCare Technologies Inc. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.6 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.6. The average price that HOLX shares were previous bought at was USD 67.0007. The current market price is 11.3% higher than average price they were purchased at. The value of the holding in HOLX has increased by USD 9,292 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 712.47 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 712.47. The average price that IDXX shares were previous bought at was USD 508.266. The current market price is 40.2% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 32,037 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 572.17 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 572.17. The average price that ISRG shares were previous bought at was USD 509.787. The current market price is 12.2% higher than average price they were purchased at. The value of the holding in ISRG has fallen by USD 200,875 compared to the previous valuation of Intuitive Surgical Inc |
| MDT - Medtronic PLC | HOLD | 0 @ USD 95.4 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 95.4. The average price that MDT shares were previous bought at was USD 89.4219. The current market price is 6.7% higher than average price they were purchased at. The value of the holding in MDT has increased by USD 488,164 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 326.28 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 326.28. The average price that PODD shares were previous bought at was USD 293.253. The current market price is 11.3% higher than average price they were purchased at. The value of the holding in PODD has increased by USD 58,173 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| RMD - ResMed Inc | HOLD | 0 @ USD 252.43 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 252.43. The average price that RMD shares were previous bought at was USD 244.86. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 47,441 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 266.7 | USD 0 | The current share valuation price of STE based on adjusted close was USD 266.7. The average price that STE shares were previous bought at was USD 229.731. The current market price is 16.1% higher than average price they were purchased at. The value of the holding in STE has increased by USD 36,842 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 363.7 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 363.7. The average price that SYK shares were previous bought at was USD 374.89. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in SYK has increased by USD 415,303 compared to the previous valuation of Stryker Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 88.5 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 88.5. The average price that ZBH shares were previous bought at was USD 102.421. The current market price is -13.6% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 6,327 compared to the previous valuation of Zimmer Biomet Holdings Inc |